Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date?
作者信息
Roth L H
出版信息
J Clin Psychopharmacol. 1983 Jun;3(3):207-8. doi: 10.1097/00004714-198306000-00036.
Abstract
摘要
Zotero 插件